4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-012272
Director sold 5,000 shares at $11.04 ($55,200)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ABERCROMBIE GEORGE B · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-18 | Exercise or conversion : show line 1 in the form | +5,000 | $3.32 | $16,600 | 5,000 | D |
| 2022-04-18 | Sale : show line 2 in the form | −5,000 | $11.04 | $55,200 | 0 | D |
| Open-market sales · 5,000 sh · avg $11.04 · $55,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-18 | Exercise or conversion : show line 3 in the form Automatic Stock Option Grant | −5,000 | 0 | D |
Loading xslF345X03/form4.xml…